MDPI and ACS Style
Damjanovska, S.; Alao, H.; Zebrowski, E.; Kowal, C.; Kostadinova, L.; Davitkov, P.; Falck-Ytter, Y.; Shive, C.L.; Cartwright, M.; Richardson, B.;
et al. During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study. Biology 2022, 11, 1262.
https://doi.org/10.3390/biology11091262
AMA Style
Damjanovska S, Alao H, Zebrowski E, Kowal C, Kostadinova L, Davitkov P, Falck-Ytter Y, Shive CL, Cartwright M, Richardson B,
et al. During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study. Biology. 2022; 11(9):1262.
https://doi.org/10.3390/biology11091262
Chicago/Turabian Style
Damjanovska, Sofi, Hawwa Alao, Elizabeth Zebrowski, Corinne Kowal, Lenche Kostadinova, Perica Davitkov, Yngve Falck-Ytter, Carey L. Shive, Michael Cartwright, Brian Richardson,
and et al. 2022. "During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study" Biology 11, no. 9: 1262.
https://doi.org/10.3390/biology11091262